The methyl ester of okadaic acid is more potent than okadaic acid in disrupting the actin cytoskeleton and metabolism of primary cultured hepatocytes
- 26 January 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 159 (2), 337-344
- https://doi.org/10.1111/j.1476-5381.2009.00512.x
Abstract
Background and purpose: Okadaic acid (OA) and microcystins (MCs) are structurally different toxins with the same mechanism of action, inhibition of serine/threonine protein phosphatases (PPs). Methyl okadaate (MeOk), a methyl ester derivative of OA, was considered almost inactive due to its weak inhibition of PP1 and PP2A. Here, we have investigated the activity and potency of MeOk in hepatic cells in comparison with that of OA and MCs. Experimental approach: We tested the effects of MeOK, OA and microcystin-leucine and arginine (MC-LR) on the metabolic rate, the actin cytoskeleton and glucose uptake in a rat hepatocyte cell line (Clone 9) and in primary cultured rat hepatocytes. PP2A was assayed to compare OA and MeOk activity. Key results: MeOk disrupted the actin cytoskeleton and depressed the metabolic rate of both types of rat hepatocytes, being six-fold less potent than OA in Clone 9 cells but nearly six-fold more potent in primary cultured hepatocytes. However, unlike OA, MeOk did not change glucose uptake in these cells, suggesting a weak inhibition of PP2A, as confirmed in direct assays of PP2A activity. Conclusions and implications: Although MeOk was originally described as a weakly bioactive molecule, it clearly depressed the metabolic rate and disrupted the cytoskeleton in primary and immortalized rat hepatocytes. Furthermore, MeOk affected primary hepatocytes at much lower concentrations than those affecting immortalized cells. These effects were unrelated to PP2A inhibition. Our results suggest the risk to public health from MeOk in foodstuffs should be re-evaluated. British Journal of Pharmacology (2010) 159, 337-344; doi: 10.1111/j.1476-5381.2009.00512.x; published online 15 December 2009This publication has 57 references indexed in Scilit:
- Cytoskeletal toxicity of pectenotoxins in hepatic cellsBritish Journal of Pharmacology, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Chemistry, Metabolism, and Chemical Analysis of Okadaic Acid Group ToxinsPublished by Taylor & Francis Ltd ,2008
- Lactone Ring of Pectenotoxins: a Key Factor for their Activity on Cytoskeletal DynamicsCellular Physiology and Biochemistry, 2007
- New Targets in Diarrhetic Shellfish Poisoning ControlJournal of Natural Products, 2005
- Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 AdipocytesMolecular and Cellular Biology, 2004
- In vivo detection of cytokeratin filament network breakdown in cells treated with the phosphatase inhibitor okadaic acidCell and tissue research, 2001
- Okadaic acid‐induced actin assembly in neutrophils: Role of protein phosphatasesJournal of Cellular Physiology, 1993
- Okadaic acid stimulates the ATP-dependent interaction between actin and myosin of smooth muscle via a direct effect on myosinBiochemical and Biophysical Research Communications, 1991
- Regulation of protein phosphatase‐1G from rabbit skeletal muscleJBIC Journal of Biological Inorganic Chemistry, 1989